caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1508856436

Wieslawa PekalM.D.

PRACTICEAMERICAN ONCOLOGY PARTNERS, P.A.See all providers at this practice →
Hematology-OncologyAsheville, NCI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,424
Unique beneficiaries
—
Total services
49,054
Distinct HCPCS
53
Medicare payment
$839K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 329 Hematology-Oncology providers in NC — top quintile (cohort median 605).
REFERRAL NETWORK

Where Wieslawa Pekal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 28 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
DLP HARRIS REGIONAL HOSPITAL LLC1551,783
Neille Wilson
Diagnostic Radiology · Sylva, NC
65274
Penny Stollery
Nurse Practitioner · Elmira, NY
50231
Gregory Pollack
Medical Oncology · Wailuku, HI
37145
THOMAS, DAVID31603
Shantae Lucas
Internal Medicine · Asheville, NC
27118
Pathologists Medical Laboratory, P.A.
Clinical Laboratory · Asheville, NC
2580
FLETCHER HOSPITAL INC.2171
CRAIN, DEBRA1740
PETERSON, NEIL1630
SELBY, WILLIAM1544
Stacey Neal
Pathology · Asheville, NC
1438
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,129
Beneficiaries
—
Total drug cost
$3.3M
Distinct drugs
36
Brand share
40.4%
Top prescribed drugs
Apixaban146 claims
Hydroxyurea93 claims
Lenalidomide81 claims
Acyclovir56 claims
Ibrutinib46 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
61
By payment type
Food and Beverage$1K
Education$26